AST SpaceMobile reports wider-than-expected loss in the first quarter of 2025, owing to macroeconomic headwinds.

US telco giant AT&T has updated its customers on the impact that satellite operator AST SpaceMobile (AST) will make when its ...

AST SpaceMobile (ASTS) delivered earnings and revenue surprises of -17.65% and 82.05%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

The AstraZeneca share price just took a hit as President Trump announced a price war against the US pharmaceutical industry.

For more information about these risks and uncertainties, please refer to the Risk Factors section of AST SpaceMobile's Annual Report on Form 10-K for the year that ended, December 31, 2024, with the ...

Enbridge Inc. ENB reported first-quarter 2025 earnings that exceeded expectations. This was driven by higher contributions ...

The AstraZeneca share price has pulled back in recent months. Dr James Fox explores how the stock compares with pharma peer GSK. The post Does the GSK or AstraZeneca share price currently offer the ...

is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period. Earnings Per Share (TTM ...

Summing up, AstraZeneca’s positioned as a growth-focused company with a higher share price relative to earnings, lower dividend yield, faster revenue growth, and a strong commitment to reducing ...

Harvey Jones says investment brokers showed their love for AstraZeneca shares at the start of the year, but maybe wondering ...

To some extent, Europe has already begun to pivot. European governments and corporations are exploring common ground with ...